ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 62 filers reported holding ASTRIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,462,238 | +37.6% | 1,000,300 | +53.7% | 2.10% | +10.8% |
| Q2 2023 | $5,421,789 | -23.0% | 650,875 | +23.0% | 1.89% | -18.5% |
| Q1 2023 | $7,040,608 | +0.1% | 529,369 | +12.0% | 2.32% | -15.8% |
| Q4 2022 | $7,035,257 | +94.6% | 472,482 | +18.1% | 2.76% | +173.4% |
| Q3 2022 | $3,616,000 | – | 400,043 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 1,347,088 | $17,916,270 | 9.94% |
| Fairmount Funds Management LLC | 1,901,397 | $25,288,580 | 4.35% |
| Ikarian Capital, LLC | 869,390 | $11,562,887 | 2.62% |
| Affinity Asset Advisors, LLC | 529,369 | $7,040,608 | 2.32% |
| Logos Global Management LP | 1,044,960 | $13,897,968 | 1.99% |
| Ghost Tree Capital, LLC | 450,000 | $5,985,000 | 1.77% |
| Vivo Capital, LLC | 1,681,199 | $22,359,947 | 1.55% |
| Opaleye Management Inc. | 302,000 | $4,096,400 | 1.23% |
| Tri Locum Partners LP | 275,011 | $3,657,646 | 1.11% |
| Saturn V Capital Management LP | 101,339 | $1,347,809 | 1.01% |